Form 4: Korro Bio CEO Ram Aiyar Acquires 50,000 Shares

Korro Bio President and CEO Ram Aiyar acquired 50,000 shares of common stock following the vesting of performance stock units.

Summary

• President and CEO Ram Aiyar acquired 50,000 shares of Korro Bio common stock on May 26, 2026.
• The acquisition resulted from the settlement and vesting of performance stock units (PSUs) granted under the 2023 Stock Option and Incentive Plan.
• The transaction occurred upon the achievement of specific performance conditions.
• Following this transaction, the reporting person directly owns 90,000 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive event, as it reflects the fulfillment of performance criteria and increases executive skin-in-the-game without indicating a new market-moving strategic shift.

Positives

• The CEO has increased his direct equity stake in the company, signaling alignment with shareholder interests.
• The vesting of performance-based equity indicates the successful achievement of internal corporate milestones.

Negatives

• None identified in this filing.

Risks

• The reporting person maintains indirect ownership through a trust, which may complicate future reporting or divestment strategies.

Future Outlook

The filing does not provide forward-looking guidance regarding company operations or financial performance.

Industry Context

StockSavvy.ai notes that executive equity vesting based on performance milestones is standard practice in the biotechnology sector to incentivize long-term value creation and align leadership with clinical or operational success.

Comparison to Industry Standards

• The use of performance stock units (PSUs) is consistent with compensation structures at peer-stage biotech firms.
• The reporting of share acquisitions via Form 4 complies with standard SEC regulatory requirements for public company executives.

Related Party Transactions

• The reporting person holds 4,613 shares through The Ram Aiyar Irrevocable Trust, for which he serves as trustee.

Stakeholder Impact

• Shareholders may view the increased direct ownership by the CEO as a positive indicator of management confidence.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Korro Bio, KRRO, Insider Trading, Form 4, Executive Compensation, Equity Vesting